CYP4A Antibodies

Santa Cruz Biotechnology delivers a wide array of CYP4A monoclonal antibodies for research focused on understanding cytochrome P450 enzymes. CYP4A Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP4A enzymes play essential roles in fatty acid metabolism and bioactive lipid synthesis, significantly impacting inflammation and vascular function regulation. The involvement of CYP4A in drug metabolism and xenobiotic detoxification highlights its importance in pharmacological and toxicological studies. Research into CYP4A function continues to reveal new insights about physiological and pathological processes. Scientists can explore CYP4A's role in various biological pathways using specific detection methods. Understanding CYP4A's mechanisms can lead to breakthroughs in therapeutic strategies and disease treatments. Investigating CYP4A's regulatory functions helps advance knowledge of metabolic disorders and cardiovascular conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cytochrome P450 enzymes and their impact on human health.